GNH USA

Europe — EMA

Lamivudine Teva Pharma B.V

GNH USA supplies Lamivudine Teva Pharma B.V (Lamivudine), a nucleoside reverse transcriptase inhibitor for HIV infection and chronic hepatitis B.

Lamivudine

Request sourcing

1
Pack/s

What is Lamivudine?

Lamivudine, the active ingredient in Lamivudine Teva Pharma B.V, is a nucleoside reverse transcriptase inhibitor (NRTI) presented as an oral tablet for oral use. It treats HIV infection and chronic hepatitis B in adult patients. The medication belongs to the antiretroviral therapeutic class and is administered under prescription.

GNH USA supplies Lamivudine Teva Pharma B.V as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide with a focus on quality assurance and regulatory compliance.

What is Lamivudine used for?

Lamivudine is used in the management of viral infections that involve reverse transcriptase activity.

- Human Immunodeficiency Virus (HIV) infection: reduces viral load and slows disease progression. - Chronic hepatitis B infection: suppresses HBV DNA replication and improves liver function. - HIV/HBV co‑infection: provides dual antiviral activity against both viruses.

What are the side effects of Lamivudine?

Lamivudine may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea - Headache - Fatigue - Diarrhea

Serious or Rare Side Effects: - Lactic acidosis - Severe hepatotoxicity - Pancreatitis

What precautions apply to Lamivudine?

Before prescribing lamivudine, clinicians should consider several safety factors.

- Renal function: assess baseline and monitor periodically. - Hepatic impairment: use with caution and check liver enzymes regularly. - Pregnancy: evaluate risk versus benefit; data are limited. - Concomitant antiretrovirals: review for additive toxicity. - Adherence: maintain consistent dosing to avoid resistance. - Store at room temperature: keep in the original container, protect from moisture and heat.

What does Lamivudine interact with?

Lamivudine can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Didanosine: increased risk of pancreatitis. - Stavudine: heightened mitochondrial toxicity. - Zidovudine: additive bone‑marrow suppression.

Moderate Interactions (Monitor Closely): - Rifampicin: reduces lamivudine plasma levels. - Efavirenz: may amplify central nervous system side effects.

Frequently asked questions

What conditions is Lamivudine Teva Pharma B.V used for?+
Lamivudine Teva Pharma B.V is indicated for the treatment of Human Immunodeficiency Virus (HIV) infection and chronic hepatitis B infection. It may also be used in patients co‑infected with both viruses to provide combined antiviral activity.
How does lamivudine work in the body?+
Lamivudine is converted inside cells to its active triphosphate form, which mimics natural nucleosides. When viral reverse transcriptase or hepatitis B DNA polymerase incorporates it into viral DNA, the chain is terminated, preventing further replication of the virus.
What is the usual dose of lamivudine?+
The specific dose of lamivudine is determined by the prescribing healthcare professional based on the patient’s condition, weight, renal function and other clinical factors. Patients should follow the exact regimen provided by their prescriber.
Is lamivudine safe during pregnancy or breastfeeding?+
Safety data for lamivudine in pregnancy and lactation are limited. The drug should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and this decision must be made by a qualified clinician.
How do I order Lamivudine Teva Pharma B.V from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does lamivudine compare with other antiretroviral drugs?+
Lamivudine belongs to the nucleoside reverse transcriptase inhibitor (NRTI) class and is often combined with other antiretrovirals for synergistic effect. Compared with some older NRTIs, lamivudine has a more favorable safety profile and a lower incidence of mitochondrial toxicity, though resistance can develop if adherence is poor.
What are the recommended storage conditions for lamivudine?+
Lamivudine tablets should be stored at room temperature, below 25 °C, in the original packaging. Protect the product from moisture, direct sunlight and excessive heat to maintain its stability throughout its shelf life.
How is lamivudine administered?+
Lamivudine is taken orally, usually as a tablet, with or without food. The exact timing and frequency are prescribed by the treating physician, who will consider the patient’s overall treatment regimen.
What are the most serious risks associated with lamivudine?+
Serious adverse events, although rare, include lactic acidosis, severe hepatotoxicity and pancreatitis. Patients should be monitored for signs such as unexplained abdominal pain, rapid breathing, jaundice or severe fatigue, and seek medical attention promptly if these occur.
Who should not use lamivudine?+
Lamivudine is contraindicated in patients with known hypersensitivity to the drug or any of its excipients. Caution is also advised for individuals with severe renal or hepatic impairment, and it should be avoided in combination with medications that have major interaction risks unless closely monitored.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Lamivudine
Route
Oral Use
Manufacturer
Teva B.V
Origin
EU

Related products